Literature DB >> 11562025

Reconstructive management of advanced breast cancer.

B Rivas1, J F Carrillo, G Escobar.   

Abstract

To evaluate morbidity, quality of life, and oncological outcomes of patients with advanced breast cancer, recurrence, or sequelae secondary to radiotherapy, the authors present their experience with 21 patients at the Instituto Nacional de Cancerología in Mexico City, who underwent resection of the lesion and reconstruction using thoracoepigastric fasciocutaneous, rectus abdominis, or latissimus dorsi musculocutaneous flaps. Complications included partial flap necrosis and bronchopleural fistulae in 2 of 7 patients with whole-thickness chest wall resection. The remaining patients progressed nicely, with a short recovery period. The patients and the surgical team evaluated results in terms of aesthetics and function using questionnaires. The results were from fair to good according to Sneeuw's scale. Pedicled musculocutaneous and fasciocutaneous flaps are an excellent reconstructive option in patients with advanced, recurrent breast cancer and in those with radionecrotic complications, which sometimes require resection of the whole-thickness chest wall.

Entities:  

Mesh:

Year:  2001        PMID: 11562025     DOI: 10.1097/00000637-200109000-00003

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Chest wall reconstruction and advanced disease.

Authors:  Elisabeth K Beahm; David W Chang
Journal:  Semin Plast Surg       Date:  2004-05       Impact factor: 2.314

2.  Using local flaps in a chest wall reconstruction after mastectomy for locally advanced breast cancer.

Authors:  Joo Seok Park; Sei Hyun Ahn; Byung Ho Son; Eun Key Kim
Journal:  Arch Plast Surg       Date:  2015-05-14

3.  Chest Wall Reconstruction with a Bilayered Wound Matrix Mesh Following Toilet Mastectomy.

Authors:  Houssein Haidar Ahmad; Gregory Nicolas; Christian Saliba; Maher A Ghandour; Nancy M Zeaiter; Hassan Alzein; Ali Kassem; Mohamad Ali Al Akhrass; Muhamed Kubaissi; Hassan Rahhal; Nada Ibrahim; Ahmad Chahrour
Journal:  Am J Case Rep       Date:  2019-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.